Weiqiang You

Yishan Road
Shanghai, 200233, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Multi-omics driven immune classification of colorectal cancer: Implications for immunotherapy efficacy prediction and enhancement with WNT signaling inhibition.

Multi-omics driven immune classification of colorectal cancer: Implications for immunotherapy efficacy prediction and enhancement with WNT signaling inhibition.

Journal: Cancer letters

Published: November 18, 2025

Integrating prognosis-related genes with immune-related gene signature for development and validation of a survival stratification model for early-stage colorectal cancer.

Integrating prognosis-related genes with immune-related gene signature for development and validation of a survival stratification model for early-stage colorectal cancer.

Journal: Translational cancer research

Published: December 10, 2024

Shaping immune landscape of colorectal cancer by cholesterol metabolites.

Shaping immune landscape of colorectal cancer by cholesterol metabolites.

Journal: EMBO molecular medicine

Published: November 01, 2023

SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.

SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.

Journal: Frontiers in immunology

Published: January 28, 2022

Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer.

Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer.

Journal: Frontiers in oncology

Published: January 05, 2022

Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.

Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.

Journal: Frontiers in immunology

Published: December 02, 2021

Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study.

Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study.

Journal: Frontiers in oncology

Published: September 14, 2021

Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study.

Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study.

Journal: Frontiers in oncology

Published: December 10, 2019

The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers.

The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers.

Journal: Journal of Cancer

Published: November 20, 2018

Downregulation of myosin VI reduced cell growth and increased apoptosis in human colorectal cancer.

Downregulation of myosin VI reduced cell growth and increased apoptosis in human colorectal cancer.

Journal: Acta biochimica et biophysica Sinica

Published: March 07, 2018

TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.

TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.

Journal: Cell death & disease

Published: October 12, 2017

Knockdown of SLC39A7 inhibits cell growth and induces apoptosis in human colorectal cancer cells.

Knockdown of SLC39A7 inhibits cell growth and induces apoptosis in human colorectal cancer cells.

Journal: Acta biochimica et biophysica Sinica

Published: July 02, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026